REV-ERB agonism improves liver pathology in a mouse model of NASH.

REV-ERB agonism improves liver pathology in a mouse model of NASH.
复制标题

DOI:
10.1371/journal.pone.0236000
复制
发表时间:
2020
期刊:
影响因子:
3.7
通讯作者:
Burris TP
Burris TP
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Griffett K;Bedia-Diaz G;Elgendy B;Burris TP

文献摘要

参考文献

被引文献

相似文献

非酒精性脂肪性肝病(NAFLD)影响着世界范围内的大量人群,目前尚无药物治疗方法。NAFLD通常表现为肥胖、胰岛素抵抗,在某些情况下还会出现心血管疾病。由于这种疾病常常发展为严重得多的非酒精性脂肪性肝炎(NASH),因此显然需要治疗方案来缓解这种疾病。REV-ERB核受体是一种转录抑制因子,调节涉及NAFLD发展的生理过程,包括脂肪生成和炎症。我们假设药理学激活REV-ERB可以抑制NASH小鼠模型中脂肪肝的进展。在小鼠NASH模型中使用REV-ERB激动剂SR9009,我们证明了REV-ERB激活的有益作用,通过抑制肝纤维化和炎症反应,导致肝脏健康的整体改善。
Non-alcoholic fatty liver disease (NAFLD) affects a significant number of people worldwide and currently there are no pharmacological treatments. NAFLD often presents with obesity, insulin resistance, and in some cases cardiovascular diseases. There is a clear need for treatment options to alleviate this disease since it often progresses to much more the much more severe non-alcoholic steatohepatitis (NASH). The REV-ERB nuclear receptor is a transcriptional repressor that regulates physiological processes involved in the development of NAFLD including lipogenesis and inflammation. We hypothesized that pharmacologically activating REV-ERB would suppress the progression of fatty liver in a mouse model of NASH. Using REV-ERB agonist SR9009 in a mouse NASH model, we demonstrate the beneficial effects of REV-ERB activation that led to an overall improvement of hepatic health by suppressing hepatic fibrosis and inflammatory response.
LXR反向激动剂SR9238在非酒精性脂肪性肝炎模型中抑制纤维化。
DOI: 10.1016/j.molmet.2015.01.009
发表时间: 2015-04
影响因子: 8.1
作者:
Griffett K;Welch RD;Flaveny CA;Kolar GR;Neuschwander-Tetri BA;Burris TP
通讯作者: Burris TP
DOI: 10.1053/j.gastro.2017.12.019
发表时间: 2018-04
期刊: Gastroenterology
影响因子: 29.4
作者:
Pourcet B;Zecchin M;Ferri L;Beauchamp J;Sitaula S;Billon C;Delhaye S;Vanhoutte J;Mayeuf-Louchart A;Thorel Q;Haas JT;Eeckhoute J;Dombrowicz D;Duhem C;Boulinguiez A;Lancel S;Sebti Y;Burris TP;Staels B;Duez HM
通讯作者: Duez HM
DOI: 10.1016/j.gene.2020.144549
发表时间: 2020-06-05
期刊: GENE
影响因子: 3.5
作者:
Feng, Gong;Li, Xue-Ping;Mi, Man
通讯作者: Mi, Man
DOI: 10.1021/cb300541g
发表时间: 2013-03-01
影响因子: 4
作者:
Griffett, Kristine;Solt, Laura A.;Burris, Thomas P.
通讯作者: Burris, Thomas P.
DOI: 10.1371/journal.pone.0189330
发表时间: 2017
期刊: PloS one
影响因子: 3.7
作者:
Stujanna EN;Murakoshi N;Tajiri K;Xu D;Kimura T;Qin R;Feng D;Yonebayashi S;Ogura Y;Yamagami F;Sato A;Nogami A;Aonuma K
通讯作者: Aonuma K